Brief: Decibel Therapeutics Reports First Quarter 2023 Financial Results And Corporate Update
15/05/2023 12:55
Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND CORPORATE UPDATE
* DECIBEL THERAPEUTICS- BELIEVES EXISTING CASH, CASH
EQUIVALENTS
AND AVAILABLE-FOR-SALE SECURITIES WILL FUND ITS PLANNED
OPERATING EXPENSES INTO H1 2024
* DECIBEL THERAPEUTICS INC - AS OF MARCH 31, 2023, CASH,
CASH
EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES WERE $87.9 MILLION
Source text for Eikon: ID:nGNX3n0637
Further company coverage: DBTX.O
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary